SCHEMBL28025616

SCHEMBL28025616

CC(C)(C)C(=O)ON1CCN(c2ccccc2[N+](=O)[O-])CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.53
KMT2A Q03164 2/20 0.53
HSD11B1 P28845 1/20 0.51
MEN1 O00255 1/20 0.49
GRM5 P41594 1/20 0.49
ENPP2 Q13822 5/20 0.47
MAPT P10636 5/20 0.47
LMNA P02545 5/20 0.46
MAPK1 P28482 2/20 0.46
GAA P10253 1/20 0.46
FAAH O00519 1/20 0.46
MGLL Q99685 1/20 0.46
ALDH1A1 P00352 2/20 0.45
MITF O75030 1/20 0.45
CCR6 P51684 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27770094 0.83 LMNA (0.43) HTTKMT2AMEN1MAPTLMNA
SCHEMBL27703769 0.83 MAPT (0.49) HTTKMT2AMEN1MAPTLMNA
SCHEMBL27615544 0.83 MAPT (0.43) HTTKMT2AMEN1GRM5ENPP2
SCHEMBL27868027 0.81 MAPT (0.60) KMT2AMEN1MAPTLMNAMAPK1
SCHEMBL27737427 0.81 MAPT (0.42) KMT2AMEN1MAPTLMNAMAPK1
SCHEMBL28752031 0.81 ALDH1A1 (0.69) HTTKMT2AMEN1MAPTLMNA
SCHEMBL30998112 0.81 MAPT (0.63) HTTKMT2AHSD11B1GRM5ENPP2
SCHEMBL4435451 0.81 MAPT (0.63) HTTKMT2AHSD11B1GRM5ENPP2
SCHEMBL27790950 0.79 ADRA2C (0.51) KMT2AMEN1MAPTLMNAMAPK1
SCHEMBL27697694 0.79 MEN1 (0.40) HTTKMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104844573-A Miazines BTK inhibitor, preparation method and medical application thereof UNIV CHINA PHARMA 2015-08-19 CN disclosed